Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
Bayer & Monsanto v. Duffy: Xtend Soybean Patent Win | PatSnap
Explore in Eureka
Case ID4:23-cv-00085
FiledJan 2023
ClosedApr 2025
Patent Litigation

Bayer & Monsanto v. Duffy: $549,500 Judgment for Willful GMO Seed Infringement

Bayer AG and Monsanto Technology LLC secured summary judgment against Missouri farmer Caleb Duffy for knowingly infringing two GM soybean patents and breaching Technology Stewardship Agreements across three crop years. The court awarded $549,500 in liquidated damages and imposed a permanent injunction — a textbook enforcement action illustrating the legal exposure facing growers who save or replant patented biotech seed.

Resolution time
814days
814 days from filing to judgment — typical for a district court summary judgment case with no trial
Patents asserted
2
US7838729B2 and US9944945B2 — Xtend soybean biotechnology and chloroplast transit peptide targeting
Outcome
Judgment on the merits for Plaintiff
Summary judgment on merits; willful infringement found on both patents for 2020–2022 crop years
Cost ruling
Costs: Plaintiff
$549,500 in liquidated damages awarded; permanent injunction entered against defendant
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

Monsanto’s Xtend Seed IP Enforcement Reaches Missouri Grower

Filed on 25 January 2023 in the Eastern District of Missouri before Judge John A. Ross, this case pits agricultural biotech giants Bayer AG and Monsanto Technology LLC against individual soybean farmer Caleb Duffy. The dispute centres on two foundational patents: US7838729B2, covering soybean event MON89788 detection methods, and US9944945B2, covering chloroplast transit peptides used to target dicamba monooxygenase (DMO) — core intellectual property underpinning Monsanto’s Xtend crop system. Plaintiffs alleged Duffy saved, planted, and replanted patented seed across the 2020, 2021, and 2022 growing seasons without authorisation, while also applying unapproved dicamba formulations past permitted deadlines.

The case closed on 18 April 2025 via summary judgment in favour of Bayer CropScience LP and Monsanto Technology LLC — meaning the court found no genuine dispute of material fact requiring trial. Duffy was found liable for both knowing and wilful patent infringement and for breaching Technology Stewardship Agreements (TSAs) covering all three crop years. The judgment quantified harm as $549,500 in liquidated damages, consistent with contractual damages provisions common in seed licensing. A permanent injunction was also entered, barring Duffy from any future use, saving, selling, or transfer of seed containing plaintiffs’ patented biotechnologies without express written permission.

An 814-day duration is consistent with a case that progressed to summary judgment without a full trial — suggesting the evidentiary record was sufficiently clear-cut to foreclose factual dispute. The wilfulness finding is commercially significant: it opens the door to enhanced damages under 35 U.S.C. § 284, though the judgment here appears premised on contractual liquidated damages rather than judicially enhanced patent damages. The public record does not disclose whether Duffy has appealed or whether any payment terms were negotiated post-judgment.

Case at a glance
Case no.4:23-cv-00085
PlaintiffBayer AG
DefendantCaleb Duffy
CourtMissouri Eastern
JudgeJohn A. Ross
FiledJanuary 25, 2023
ClosedApril 18, 2025
Duration814 days
OutcomeJudgment on the merits for Plaintiff
Verdict causeInfringement Action
BasisJudgment on the merits for Plaintiff
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Missouri Eastern District Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Judgment on the merits for Plaintiff in 814 days

814 days from filing to judgment — typical for a district court summary judgment case with no trial

Case timeline: Complaint filed JAN 25 2023, MAR–APR — 814 days total Horizontal timeline showing the three key events in Bayer AG v Caleb Duffy from filing to resolution. Source: PACER, Missouri Eastern District Court. JAN 25 2023 Complaint filed Pre-trial proceedings APR 18 2025 Judgment on the merits for Plaintiff 814 DAYS TOTAL
Court ruling

Summary judgment for Bayer & Monsanto: what the ruling means for both parties

Legal mechanism

Summary judgment on willful infringement — no trial required

The court entered summary judgment, meaning plaintiffs demonstrated that no genuine issue of material fact existed regarding infringement or breach of the TSAs. A wilfulness finding at summary judgment is notable: it indicates Duffy’s conduct was sufficiently documented — likely through seed purchase records, field inspections, and TSA records — that the court could resolve liability without a jury. Wilful infringement typically supports enhanced damages under 35 U.S.C. § 284.

Summary judgment — no trial
Patent holder outcome

Full relief: damages, injunction, and wilfulness on record

Bayer and Monsanto achieved the maximum available relief at this stage: a liquidated damages award of $549,500 grounded in TSA terms, a permanent injunction preventing any further use of patented seed technologies, and a court-endorsed wilfulness finding. The injunction is particularly powerful — it extends to all Plaintiffs’ patented biotechnologies, not just the specific varieties used in 2020–2022, reinforcing Monsanto’s ability to enforce seed IP broadly against this defendant.

Full injunctive + monetary relief
Grower outcome

Permanent injunction and six-figure damages liability for seed saving

Duffy faces a $549,500 liquidated damages judgment and a court-ordered permanent injunction barring future use of Plaintiffs’ biotech seed without written permission. The injunction also specifically prohibits post-deadline dicamba applications to Xtend crops. For an individual farmer, this represents substantial financial and operational exposure. The wilfulness finding on record would complicate any future appeal on damages quantum. No settlement or appeal information is publicly disclosed.

Six-figure liability + permanent ban
Commercial implications

A precedent reinforcing Monsanto’s seed enforcement playbook

This judgment is consistent with Monsanto’s decades-long strategy of using TSAs as both a licensing tool and an enforcement mechanism. The liquidated damages clause in the TSA effectively pre-quantifies harm, making summary judgment more attainable. For the broader agri-biotech sector, the case signals that wilful seed saving — even by individual growers — remains vigorously prosecuted. R&D teams developing competing biotech traits should treat US7838729B2 and US9944945B2 as live, actively enforced IP.

Active IP enforcement signal
Legal analysis based on PACER docket records for case 4:23-cv-00085 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffBayer AGCompanyAgricultural biotech conglomerate — holder of US7838729B2 and US9944945B2Search in Eureka ↗
Co-PlaintiffMonsanto Technology, LLCCompanySearch in Eureka ↗
DefendantCaleb DuffyIndividualIndividual Missouri soybean farmer alleged to have saved and replanted patented Xtend seedSearch in Eureka ↗
Plaintiff counselAnthony F. BlumAttorneyCounsel for Bayer AGSearch in Eureka ↗
Plaintiff counselDaniel C. CoxAttorneyCounsel for Bayer AGSearch in Eureka ↗
Plaintiff counselJeffrey A. MassonAttorneyCounsel for Bayer AGSearch in Eureka ↗
Plaintiff counselMatthew S. BoberAttorneyCounsel for Bayer AGSearch in Eureka ↗
Plaintiff law firmThompson Coburn LLP (St Louis)Law FirmRepresenting Bayer AGSearch in Eureka ↗
Defendant counselWendell L. Hoskins , IIAttorneyCounsel for Caleb DuffySearch in Eureka ↗
Defendant law firmHoskins Law OfficeLaw FirmRepresenting Caleb DuffySearch in Eureka ↗
Presiding judgeJudge John A. RossJudgeMissouri Eastern District CourtSearch in Eureka ↗
Official verdict

Official order — verbatim text

“In accordance with the Memorandum and Order entered this day and incorporated herein, IT IS HEREBY ORDERED, ADJUDGED and DECREED that summary judgment is entered in favor of Plaintiffs Bayer CropScience LP and Monsanto Technology LLC and against Defendant Caleb Duffy. Defendant is liable for knowingly and willfully infringing Plaintiffs’ ‘945 and ‘729 patents and for breaching the parties’ Technology Stewardship Agreements for 2020, 2021, and 2022. Judgment is entered for Plaintiffs and against Defendant in the amount of $549,500 in liquidated damages, and Defendant is permanently enjoined from (1) making, using, saving, planting, selling, offering to sell, importing, or otherwise transferring any soybean or other seed containing Plaintiffs’ patented biotechnologies without express written permission and (2) applying unapproved formulations of dicamba-based herbicides to Xtend crops, including doing so after applicable deadlines.”
Source: PACER Docket, Case 4:23-cv-00085, Missouri Eastern District Court

The verdict’s explicit wilfulness language — ‘knowingly and willfully infringing’ — carries weight beyond mere liability. Under 35 U.S.C. § 284, wilful infringement allows courts to award up to treble damages, though the judgment here appears premised on contractual liquidated damages rather than judicially enhanced patent damages. The dual basis of liability (patent infringement and TSA breach) is strategically significant: it gives Bayer and Monsanto parallel enforcement tracks. The permanent injunction’s breadth, covering all patented biotechnologies rather than only those at issue, suggests the court accepted plaintiffs’ framing of Duffy as a systemic rather than incidental infringer.

PACER case 4:23-cv-00085 · Public docket record Explore in Eureka ↗
Patent at issue

US7838729B2 & US9944945B2 — Xtend Soybean Biotechnology Patents

Publication No.US7838729B2
Application No.US11/758659
Patent details
Productsoybean event MON89788 detection methods and compositions
Cited in actionJanuary 25, 2023

Publication No.US9944945B2
Application No.US14/539923
Patent details
Productchloroplast transit peptides for DMO targeting and dicamba-tolerant crop expression
Cited in actionJanuary 25, 2023

US7838729B2 (application no. US11/758659) covers soybean event MON89788 — the specific transgenic insertion event that defines Roundup Ready 2 Yield soybeans — and methods for its detection. US9944945B2 (application no. US14/539923) protects chloroplast transit peptides engineered to efficiently deliver dicamba monooxygenase (DMO) into plant plastids, enabling dicamba herbicide tolerance in Xtend crops. Together, these patents protect both the genetic identity of the soybean event and the molecular machinery enabling the herbicide-tolerance trait — covering detection, expression, and use.

For the agri-biotech sector, these two patents represent complementary layers of protection: one controls the ability to identify the patented event (enabling enforcement against seed savers), while the other controls the functional herbicide-tolerance mechanism. Any competitor seeking to develop dicamba-tolerant soybeans or detect the MON89788 event must navigate both assets. The court’s willingness to enter summary judgment on both simultaneously confirms that the patents are enforceable in combination and that Bayer/Monsanto’s enforcement infrastructure — including TSAs and field inspections — is sufficiently robust to meet the evidentiary standard without trial.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should you run an FTO against US7838729B2 and US9944945B2?

Any R&D team or agri-biotech company developing herbicide-tolerant soybean traits, GM event detection assays, or chloroplast-targeted enzyme delivery systems should treat these patents as high-priority FTO targets. The Duffy judgment confirms both patents are actively enforced and litigation-ready. Seed companies licensing Xtend technology, as well as competitors developing alternative DMO-based or plastid-targeting approaches, face direct infringement exposure if their products overlap with the claims of either patent.

PatSnap Eureka’s FTO Search Agent can map the full claim scope of US7838729B2 and US9944945B2 against your product pipeline, flag design-around opportunities, and surface the broader Xtend patent family — including continuation and divisional applications that may extend protection beyond these two grants. Eureka’s prior art and validity analysis tools also let you assess whether either patent presents IPR or ex parte reexamination opportunities before committing to a design-around or licensing strategy.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US7838729B2 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar GM Seed Patent Enforcement Cases in U.S. District Courts

Explore comparable Monsanto and Bayer biotech seed patent infringement cases filed in U.S. district courts involving TSA breaches and GMO trait enforcement.

🔍
Access 40+ similar cases in PatSnap Eureka
Bayer AG patent enforcement history, Missouri Eastern case history, Bayer AG’s full IP portfolio, and comparable case analysis
Monsanto v. farmer — E.D. Mo.Xtend patent TSA breach casesMON89788 infringement actionsDicamba trait enforcement suits
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the agri-biotech IP enforcement landscape

Bayer and Monsanto’s summary judgment win reinforces the potency of TSA-backed patent enforcement against downstream seed users.

TSA liquidated damages clauses make summary judgment more achievable

By embedding liquidated damages in Technology Stewardship Agreements, Monsanto pre-establishes the quantum of harm — eliminating a key factual dispute that would otherwise require trial. Companies licensing biotech IP through click-wrap or paper TSAs should audit whether their clauses are sufficiently specific to survive summary judgment scrutiny.

Wilfulness findings at summary judgment set a high bar for growers

A wilfulness finding without trial signals that the evidentiary record — likely including purchase receipts, field inspection reports, and TSA acknowledgment logs — was unambiguous. Seed companies should ensure their audit and compliance programmes generate this level of documentary evidence as a matter of routine enforcement infrastructure.

🔒
Full strategic analysis in PatSnap Eureka
Unlock full strategic analysis on agri-biotech patent enforcement in U.S. district courts, including TSA risk benchmarking.
FTO risk for GMO traitsTSA clause benchmarkingXtend patent family map
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

Bayer v Caleb — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Monitor GM Crop Patent Enforcement Before It Affects Your Pipeline

This case confirms Bayer and Monsanto’s Xtend patents are litigation-active. Run an FTO against US7838729B2 and US9944945B2 with PatSnap Eureka, and set up alerts for new enforcement actions across the GM soybean IP landscape.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.